The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its position within the broader sector now triggers questions about potential returns . Generic versions are undercutting market share, causing worries that investing in companies heavily reliant to Viagra's once-dominant standing could be a pro